Literature DB >> 27598632

Prevalence and factors associated with latent tuberculosis infection in an indigenous population in the Brazilian Amazon.

Jocieli Malacarne1, Diana Patricia Giraldo Rios1, Cosme Marcelo Furtado Passos da Silva2, José Ueleres Braga2, Luiz Antonio Bastos Camacho2, Paulo Cesar Basta3.   

Abstract

INTRODUCTION: Recent studies have shown a high incidence and prevalence of latent tuberculosis infection (LTBI) in indigenous populations around the World. We aimed to estimate the prevalence and annual risk of infection (ARI) as well as to identify factors associated with LTBI in an indigenous population from the Brazilian Amazon.
METHODS: We conducted a cross-sectional study in 2011. We performed tuberculin skin tests (TSTs), smears and cultures of sputum samples, and chest radiographs for individuals who reported cough for two or more weeks. Associations between LTBI (TST ≥5mm) and socio-demographic, clinical, and epidemiological characteristics were investigated using Poisson regression with robust variance. Prevalence ratio (PR) was used as the measure of association.
RESULTS: We examined 263 individuals. The prevalence of LTBI was 40.3%, and the ARI was 2.4%. Age ≥15 years [PR=5.5; 95% confidence interval (CI): 3.5-8.6], contact with tuberculosis (TB) patients (PR=3.8; 95% CI: 1.2-11.9), previous TB history (PR=1.4; 95% CI: 1.2-1.7), and presence of Bacillus Calmette-Guérin (BCG) scar (PR=1.9, 95% CI: 1.2-2.9) were associated with LTBI.
CONCLUSIONS: Although some adults may have been infected years prior, the high prevalence of infection and its strong association with age ≥15 years, history of TB, and recent contact with TB patients suggest that the TB transmission risk is high in the study area.

Entities:  

Mesh:

Year:  2016        PMID: 27598632     DOI: 10.1590/0037-8682-0220-2016

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

1.  Genetic Clustering of Tuberculosis in an Indigenous Community of Brazil.

Authors:  Flávia Patussi Correia Sacchi; Mariana Bento Tatara; Camila Camioli de Lima; Liliane Ferreia da Silva; Eunice Atsuko Cunha; Vera Simonsen; Lucilaine Ferrazoli; Harrison Magdinier Gomes; Sidra Ezidio Gonçalves Vasconcellos; Philip Noel Suffys; Jason R Andrews; Julio Croda
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

2.  Performance of diagnostic tests for pulmonary tuberculosis in indigenous populations in Brazil: the contribution of Rapid Molecular Testing.

Authors:  Jocieli Malacarne; Alexsandro Santos Heirich; Eunice Atsuko Totumi Cunha; Ida Viktoria Kolte; Reinaldo Souza-Santos; Paulo Cesar Basta
Journal:  J Bras Pneumol       Date:  2019-04-18       Impact factor: 2.624

3.  The contribution of stigma to the transmission and treatment of tuberculosis in a hyperendemic indigenous population in Brazil.

Authors:  Ida Viktoria Kolte; Lucia Pereira; Aparecida Benites; Islândia Maria Carvalho de Sousa; Paulo Cesar Basta
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

4.  Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous population.

Authors:  S A Hadi; I V Kolte; E P Brenner; E A T Cunha; V Simonsen; L Ferrazoli; D A M Villela; R S Santos; J Ravi; S Sreevatsan; P C Basta
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

5.  Diagnostic Potential of the Serological Response to Synthetic Peptides from Mycobacterium tuberculosis Antigens for Discrimination Between Active and Latent Tuberculosis Infections.

Authors:  Zaida Araujo; Jacobus H de Waard; Milena Camargo; Juan Ernesto Lopez-Ramos; Carlos Fernández de Larrea; Magnolia Vanegas; Manuel A Patarroyo
Journal:  Int J Pept Res Ther       Date:  2022-05-03       Impact factor: 2.191

6.  Factors associated with TB in an indigenous population in Brazil: the effect of a cash transfer program.

Authors:  Jocieli Malacarne; Ida Viktoria Kolte; Lais Picinini Freitas; Jesem Douglas Yamall Orellana; Maximiliano Loiola Ponte de Souza; Reinaldo Souza-Santos; Paulo Cesar Basta
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-10-25       Impact factor: 1.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.